Breaking news: Largest Breast AI Study Ever Read News

Smart AI for early breast cancer detection and diagnosis

We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less intense.

CE marked and FDA cleared 

LEARN ABOUT OUR CLINICAL EVIDENCE HERE

An introduction to Screenpoint

Here’s a short introduction to what we do

Why Transpara?

Trusted in more than 30 countries

Trusted in more than 30 countries

FDA cleared and CE marked for 2D and 3D mammography

FDA cleared and CE marked for 2D and 3D mammography

The most independent peer reviewed publications in breast AI

The most independent peer reviewed publications in breast AI

Proven multivendor compatibility

Proven multivendor compatibility

Integrated with most workstations

Integrated with most workstations

Experience the benefit of our continuously evolving deep learning algorithm

Experience the benefit of our continuously evolving deep learning algorithm

Peer Reviewed Publications

Accuracy.
Workload Reduction.
Risk.

"Transpara has the potential to detect specific cancers earlier. I can think of 1-2 recent cases with calcifications, where Transpara detected a cancer earlier that was not easily visible on a mammogram."

Dr Brian Englander

Dr Englander, Robert E. Campbell Professor of Clinical Radiology, Perelman School of Medicine Chairman, Department of Radiology, Pennsylvania Hospital Penn Center for Global Health Scholar

"Transpara increases my confidence and efficiency going through a screening mammography session. I have more focus especially with the higher risk cases thanks to their Intuitive Triage software."

Dr Roger Yang

MD, FACR, University Radiology Group

"I use Transpara all the time, and won't read another 3D mammogram without it. The product fits seamlessly into our workflow, and we have found over time it has increased our mammography workflow. Thanks to the technology's score card we are also able to focus on those high risk patients first, and get those patients the care they may need faster."

Dr Daniel Gurell

Vice President and Associate Medical Director at University Diagnostic Medical Imaging P.C.USA

“Transpara may allow discriminating studies, which require more attention and selection of those, which may be handled with single reading for example. It may thus contribute significantly to both risk adapted screening and optimum assignment of resources."

Professor Sylvia H Heywang-Köbrunner

Radiologist, Head of the Referenzzentrum Mammographie Munich, Germany

"We are at the forefront of one of the first prospective studies with Transpara. As we will implement Transpara in a real-life screening setting in Ostergotland County, we aim to improve the quality of the breast cancer screening program while at the same time safely reduce the workload of breast radiologists."

Håkan Gustafsson

Deputy Director CMIV, AI Coordinator at Region Östergötland

The Transpara Process

The Transpara Process
Client scan

Client scan

Client undergoes mammogram

Analyze scan

Analyze scan

Transpara analyses mammogram scan

Reading with Transpara

Reading with Transpara

Radiologist reads with support from Transpara, increasing confidence in decision

Result

Make more accurate and consistent decision

News

Announcement


Transpara breast AI; strong clinical evidence evolves into real life screening use

Safely reducing radiologists’ workload for 2D and 3D mammography screening The Transpara AI breast care solution, now being used in

Read more

Publication


Transpara® breast AI reduces false positives and radiologists’ workload in largest Danish screening programme

The team running the country’s largest breast screening programme have shown that using Transpara breast AI further confirmed the enormous

Read more

Publication


The largest breast AI study to date shows value of Transpara in mammographic screening

In a recent study, the Cancer Registry of Norway used over 120,000 screening examinations from a population-based program to assess potential

Read more

Announcement


ScreenPoint Medical appoints new CEO

Following the success of the world’s leading AI Breast Care system, Transpara®, now in use across the US and in

Read more

Publication


A study with over 2,000 cancers missed by screening shows that Transpara AI can effectively help detect breast cancer earlier

ScreenPoint Medical’s Transpara AI decision support system can help radiologists to identify potential breast cancers earlier and faster, according to

Read more

Announcement


Transpara AI Breast Care – Global Expansion planned for 2022

Following the success of the world’s leading AI Breast Care system, Transpara®, now in use across the US and in

Read more